Breast Cancer Clinical Trials

Breast Cancer Clinical Trials

Clinical Trial: Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer (GeparSixto)

Clinical Trial: Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer (GeparSixto) Sponsor and CollaboratorsGerman Breast Group, Cephalon, Roche Pharma AG, GlaxoSmithKline Principal InvestigatorGunter von Minckwitz, MD, Prof, ASCO, AACR, ESMO, DKG, DGGG, AGO, DGS, BIG, BCIRG, St. Gallen Consensus Panel ClinicalTrials.gov Identifier NCT01426880 Continue Reading

Next post in Breast Cancer Clinical Trials